We are live on ! Find out more
OCS icon

Oculis Holding
OCS

57 hedge funds and large institutions have $535M invested in Oculis Holding in 2026 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

229% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 7

47% more capital invested

Capital invested by funds: $364M → $535M (+$171M)

39% more funds holding

Funds holding: 41 → 57 (+16)

20% more funds holding in top 10

Funds holding in top 10: 5 → 6 (+1)

0.19% more ownership

Funds ownership: 34.51% → 34.71% (+0.19%)

0% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 11

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $13K

Holders
57
Holders Change
+16
Holders Change %
+39.02%
% of All Funds
0.7%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.07%
New
23
Increased
11
Reduced
11
Closed
7
Calls
–
Puts
$13K
Net Calls
-$13K
Net Calls Change
-$13K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$23.8M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$22.1M
3
EAM
Eventide Asset Management
Massachusetts
+$11.4M
4
F
Folketrygdfondet
Norway
+$3.62M
5
HF
HRT Financial
New York
+$2.76M

Top Sellers

Rank Fund Capital Flow
1
PBPIA
Pivotal bioVenture Partners Investment Advisor
California
-$16.1M
2
NFGH
Nan Fung Group Holdings
Hong Kong
-$4.34M
3
NICM
Neo Ivy Capital Management
New York
-$2.55M
4
PBM
Propel Bio Management
California
-$1.34M
5
Marshall Wace
Marshall Wace
United Kingdom
-$914K
Name Holding Trade Value Shares
Change 		Change in
Stake
SAM
26
Simplify Asset Management
Nevada
$1.77M -$850K -32,098 -32%
Morgan Stanley
27
Morgan Stanley
New York
$1.76M +$1.67M +63,187 +2,072%
UBS Group
28
UBS Group
Switzerland
$1.67M +$446K +16,830 +37%
Geode Capital Management
29
Geode Capital Management
Massachusetts
$1.57M +$605K +22,864 +63%
Point72 Asset Management
30
Point72 Asset Management
Connecticut
$1.49M +$1.49M +56,127 New
JP Morgan Chase
31
JP Morgan Chase
New York
$1.3M +$1.32M +49,865 +1,568%
AA
32
ALPS Advisors
Colorado
$1.24M -$10.8K -408 -0.9%
TI
33
Trexquant Investment
Connecticut
$1.18M +$1.17M +44,238 New
YIH
34
Y-Intercept (HK)
Hong Kong
$776K +$773K +29,197 New
Tudor Investment Corp
35
Tudor Investment Corp
Connecticut
$768K +$765K +28,894 New
QC
36
Quadrature Capital
United Kingdom
$678K +$675K +25,482 New
BFM
37
Boothbay Fund Management
New York
$664K +$661K +24,960 New
XT
38
XTX Topco
Cayman Islands
$612K +$609K +23,023 New
Northern Trust
39
Northern Trust
Illinois
$563K – – –
Qube Research & Technologies (QRT)
40
Qube Research & Technologies (QRT)
United Kingdom
$545K +$542K +20,490 New
State Street
41
State Street
Massachusetts
$505K +$172K +6,481 +52%
HCS
42
Himension Capital (Singapore)
Singapore
$503K +$501K +18,926 New
CC
43
Centiva Capital
New York
$482K +$480K +18,145 New
Squarepoint
44
Squarepoint
New York
$384K +$382K +14,447 New
AC
45
AXQ Capital
New Jersey
$375K +$374K +14,118 New
PWM
46
Palumbo Wealth Management
New York
$365K +$363K +13,711 New
Koshinski Asset Management
47
Koshinski Asset Management
Illinois
$238K +$237K +8,937 New
SPS
48
Susquehanna Portfolio Strategies
Pennsylvania
$227K +$226K +8,524 New
BNP Paribas Financial Markets
49
BNP Paribas Financial Markets
France
$134K +$38.4K +1,450 +40%
APW
50
Aventura Private Wealth
Florida
$106K – – –
1
2
3

OCS Hedge Fund Activity: Q1 2026 in Review

57 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Oculis Holding (OCS) for Q1 2026, worth a combined $535M — up 47% from $364M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new OCS positions and 7 closed out — a net gain of 16 holders — while 11 added to existing stakes and 11 trimmed.

The largest buyer was Millennium Management, adding an estimated $23.8M. The largest seller was Pivotal bioVenture Partners Investment Advisor, cutting an estimated $16.1M.

  • 57 institutional investors held Oculis Holding (OCS) as of Q1 2026, up from 41 in Q4 2025.
  • Funds reported $535M of Oculis Holding stock for Q1 2026, up 47% quarter-over-quarter.
  • 23 funds opened new Oculis Holding positions in Q1 2026 and 7 closed out, a net change of +16 holders.
  • The largest Oculis Holding buyer in Q1 2026 was Millennium Management, an estimated $23.8M added.
  • The largest Oculis Holding seller in Q1 2026 was Pivotal bioVenture Partners Investment Advisor, an estimated $16.1M sold.

Based on aggregated 13F filings for Q1 2026.